---
document_datetime: 2023-09-21 20:48:08
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/marixino-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: marixino-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 2.3494685
conversion_datetime: 2025-12-19 23:21:57.001212
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Marixino

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                            | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| N/0015               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification) | 06/12/2021                          |                                             | PL                               |           |
| IB/0014              | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation   | 06/11/2020                          | 18/11/2021                                  | SmPC, Annex II, Labelling        |           |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |            |            | and PL                 |                 |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------|
| T/0013    | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 16/03/2018 | 04/04/2018 | SmPC, Labelling and PL |                 |
| R/0012    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 12/10/2017 | 18/01/2018 | SmPC, Labelling and PL |                 |
| IA/0011/G | This was an application for a group of variations. A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch | 29/06/2017 | n/a        |                        | control/testing |
| IB/0010   | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                                                                                                                                                                                                     | 05/04/2017 | 18/01/2018 | SmPC and PL            |                 |
| IB/0009   | B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data                                                                                                                                                                                                                                                                                                                                                                                                        | 03/03/2017 | n/a        |                        |                 |

<div style=\"page-break-after: always\"></div>

| IB/0008   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                  | 11/05/2016   | 16/06/2017   | SmPC, Annex II, Labelling and PL   |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------------------|
| IAIN/0007 | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location | 11/08/2015   | n/a          |                                    |
| IAIN/0006 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                              | 02/02/2015   | n/a          |                                    |
| N/0005    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                | 19/01/2015   | 16/06/2017   | PL                                 |
| IA/0004   | B.I.a.3.a - Change in batch size (including batch size ranges) of AS or intermediate - Up to 10-fold increase compared to the originally approved batch size    | 24/10/2013   | n/a          |                                    |
| IAIN/0003 | A.2.a - Administrative change - Change in the (invented) name of the medicinal product for CAPs                                                                 | 09/08/2013   | 26/08/2014   | SmPC, Labelling and PL             |
| T/0002    | Transfer of MA from Krka d.d. Novo mesto to Consilient Health Ltd Transfer of Marketing Authorisation                                                           | 08/07/2013   | 05/08/2013   | SmPC, Labelling and PL             |